These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 22365247)
21. [The expressions and meanings of BMP-7 and TGF-β in idiopathic pulmonary fibrosis and idiopathic nonspecific interstitial pneumonia]. Gu P; Luo B; Yi X; Zhu H; Li S; Yu X; Han F; Zhang S; Zhu X; Rui W; Qiu W; Fan D Zhonghua Jie He He Hu Xi Za Zhi; 2014 Sep; 37(9):664-70. PubMed ID: 25533688 [TBL] [Abstract][Full Text] [Related]
22. Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors. Farkas L; Gauldie J; Voelkel NF; Kolb M Am J Respir Cell Mol Biol; 2011 Jul; 45(1):1-15. PubMed ID: 21057104 [TBL] [Abstract][Full Text] [Related]
23. Signaling pathways and their miRNA regulators involved in the etiopathology of idiopathic pulmonary fibrosis (IPF) and hypersensitivity pneumonitis (HP). Kiszałkiewicz J; Piotrowski W; Brzeziańska-Lasota E Adv Respir Med; 2017; 85(3):169-178. PubMed ID: 28667660 [TBL] [Abstract][Full Text] [Related]
24. Personalized medicine in idiopathic pulmonary fibrosis: facts and promises. Spagnolo P; Tzouvelekis A; Maher TM Curr Opin Pulm Med; 2015 Sep; 21(5):470-8. PubMed ID: 26132817 [TBL] [Abstract][Full Text] [Related]
25. Putting the brakes on age-related idiopathic pulmonary fibrosis: can Nox4 inhibitors suppress IPF? Turn CS; Lockey RF; Kolliputi N Exp Gerontol; 2015 Mar; 63():81-2. PubMed ID: 25668226 [No Abstract] [Full Text] [Related]
36. Idiopathic pulmonary fibrosis: an Australian perspective. Prasad J; Holland AE; Glaspole I; Westall G Intern Med J; 2016 Jun; 46(6):663-8. PubMed ID: 27257148 [TBL] [Abstract][Full Text] [Related]
37. The disturbed redox-balance in pulmonary fibrosis is modulated by the plant flavonoid quercetin. Veith C; Drent M; Bast A; van Schooten FJ; Boots AW Toxicol Appl Pharmacol; 2017 Dec; 336():40-48. PubMed ID: 28987380 [TBL] [Abstract][Full Text] [Related]
38. Exploitation of Novel Molecular Targets to Treat Idiopathic Pulmonary Fibrosis: A Drug Discovery Perspective. Vaidya B; Patel R; Muth A; Gupta V Curr Med Chem; 2017; 24(22):2439-2458. PubMed ID: 28552057 [TBL] [Abstract][Full Text] [Related]
39. Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis. Espindola MS; Habiel DM; Narayanan R; Jones I; Coelho AL; Murray LA; Jiang D; Noble PW; Hogaboam CM Am J Respir Crit Care Med; 2018 Jun; 197(11):1443-1456. PubMed ID: 29634284 [TBL] [Abstract][Full Text] [Related]
40. Current clinical trials for the treatment of idiopathic pulmonary fibrosis. Klingsberg RC; Mutsaers SE; Lasky JA Respirology; 2010 Jan; 15(1):19-31. PubMed ID: 20199632 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]